Fürst D, Müller C, Vucinic V, et al. High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis. Blood. 2013;122(18):3220-3229.

doi:10.1182/blood-2014-01-553776

On page 3226 of the 31 October 2013 issue, there is an error in Table 7. The row headers “Donor-recipient gender” and “Donor-recipient CMV status*” are incorrect. The row headers should read “Recipient-donor gender” and “Recipient-donor CMV status*,” respectively. The corrected Table 7 is shown.

2014

Predictor

DFS

TRM

95% CI

HLA match

10/10

1511

1.00

1511

1.00

1509

1.00

9/10

803

1.26

1.11-1.43

<.001

803

1.17

1.03-1.32

.012

803

1.38

1.15-1.66

<.001

8/10

247

1.86

1.51-2.29

<.001

247

1.71

1.40-2.09

<.001

247

2.13

1.64-2.77

<.001

Disease stage

Early

1047

1.00

1047

1.00

1047

1.00

Intermediate

922

1.46

1.26-1.70

<.001

922

1.50

1.31-1.73

<.001

921

1.60

1.29-1.98

<.001

Advanced

677

2.18

1.87-2.54

<.001

677

2.17

1.88-2.51

<.001

676

1.97

1.59-2.43

<.001

Patient age (years)

<40

734

1.00

734

1.00

733

1.00

40-55

951

1.39

1.19-1.62

<.001

951

1.30

1.13-1.50

<.001

950

1.60

1.27-2.00

<.001

>55

961

1.76

1.48-2.10

<.001

961

1.56

1.33-1.82

<.001

961

1.85

1.43-2.40

<.001

Recipient-donor gender

Male-male

1227

1.00

1227

1.00

1227

1.00

Male-female

362

1.13

0.95-1.34

.170

362

1.15

0.98-1.35

.087

362

0.96

0.75-1.22

.720

Female-female

393

0.91

0.77-1.08

.270

393

0.92

0.78-1.08

.300

392

0.67

0.51-0.88

.004

Female-male

664

0.99

0.86-1.14

.870

664

0.98

0.86-1.13

.810

663

0.91

0.74-1.12

.390

Year of transplantation

1997-2003

455

1.00

455

1.00

455

1.00

2004-2010

2191

0.76

0.64-0.91

.002

2191

0.79

0.67-0.93

.005

2189

0.61

0.49-0.76

<.001

Recipient-donor CMV status*

Negative-negative

520

1.00

520

1.00

520

1.00

Negative-positive

183

1.40

1.08-1.81

.099

183

1.34

1.05-1.71

.017

183

1.23

0.84-1.79

.290

Positive-negative

479

1.20

0.98-1.47

.081

479

1.16

0.96-1.40

.140

478

1.27

0.95-1.70

.100

Positive-positive

539

1.13

0.93-1.38

.210

539

1.11

0.93-1.34

.260

539

1.13

0.85-1.51

.400

Patient KIR ligand status

C1C1 or C1C2

2244

1.00

2244

1.00

2242

1.00

C2C2

402

1.26

1.09-1.47

.027

402

1.30

1.13-1.50

.002

402

1.14

0.91-1.42

.240

Donor origin

National

2091

1.00

2091

1.00

2090

1.00

International

555

1.23

1.07-1.41

.004

555

1.23

1.08-1.41

.002

554

1.29

1.06-1.56

.010

Predictor

DFS

TRM

95% CI

HLA match

10/10

1511

1.00

1511

1.00

1509

1.00

9/10

803

1.26

1.11-1.43

<.001

803

1.17

1.03-1.32

.012

803

1.38

1.15-1.66

<.001

8/10

247

1.86

1.51-2.29

<.001

247

1.71

1.40-2.09

<.001

247

2.13

1.64-2.77

<.001

Disease stage

Early

1047

1.00

1047

1.00

1047

1.00

Intermediate

922

1.46

1.26-1.70

<.001

922

1.50

1.31-1.73

<.001

921

1.60

1.29-1.98

<.001

Advanced

677

2.18

1.87-2.54

<.001

677

2.17

1.88-2.51

<.001

676

1.97

1.59-2.43

<.001

Patient age (years)

<40

734

1.00

734

1.00

733

1.00

40-55

951

1.39

1.19-1.62

<.001

951

1.30

1.13-1.50

<.001

950

1.60

1.27-2.00

<.001

>55

961

1.76

1.48-2.10

<.001

961

1.56

1.33-1.82

<.001

961

1.85

1.43-2.40

<.001

Recipient-donor gender

Male-male

1227

1.00

1227

1.00

1227

1.00

Male-female

362

1.13

0.95-1.34

.170

362

1.15

0.98-1.35

.087

362

0.96

0.75-1.22

.720

Female-female

393

0.91

0.77-1.08

.270

393

0.92

0.78-1.08

.300

392

0.67

0.51-0.88

.004

Female-male

664

0.99

0.86-1.14

.870

664

0.98

0.86-1.13

.810

663

0.91

0.74-1.12

.390

Year of transplantation

1997-2003

455

1.00

455

1.00

455

1.00

2004-2010

2191

0.76

0.64-0.91

.002

2191

0.79

0.67-0.93

.005

2189

0.61

0.49-0.76

<.001

Recipient-donor CMV status*

Negative-negative

520

1.00

520

1.00

520

1.00

Negative-positive

183

1.40

1.08-1.81

.099

183

1.34

1.05-1.71

.017

183

1.23

0.84-1.79

.290

Positive-negative

479

1.20

0.98-1.47

.081

479

1.16

0.96-1.40

.140

478

1.27

0.95-1.70

.100

Positive-positive

539

1.13

0.93-1.38

.210

539

1.11

0.93-1.34

.260

539

1.13

0.85-1.51

.400

Patient KIR ligand status

C1C1 or C1C2

2244

1.00

2244

1.00

2242

1.00

C2C2

402

1.26

1.09-1.47

.027

402

1.30

1.13-1.50

.002

402

1.14

0.91-1.42

.240

Donor origin

National

2091

1.00

2091

1.00

2090

1.00

International

555

1.23

1.07-1.41

.004

555

1.23

1.08-1.41

.002

554

1.29

1.06-1.56

.010

Fürst D, Müller C, Vucinic V, et al. High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis. Blood. 2013;122(18):3220-3229.

Contents

Data & Figures

Supplemental data

References

Cited By

Email alerts

ASH Publications

American Society of Hematology

Fürst D, Müller C, Vucinic V, et al. High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis. Blood. 2013;122(18):3220-3229.

Contents

Data & Figures

Supplemental data

References

Related

Related

Cited By

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only